VYLOY 20 mg/mL
ZOLBETUXIMAB · INJECTION, POWDER, FOR SUSPENSION · Astellas Pharma US, Inc.
VYLOY is a injection, powder, for suspension containing zolbetuximab at 20 mg/mL, taken intravenous. Manufactured by Astellas Pharma US, Inc..
Key Facts
- Brand Name
- VYLOY
- Generic Name
- ZOLBETUXIMAB
- NDC Code (Product)
0469-4425- Manufacturer
- Astellas Pharma US, Inc.
- Strength
- 20 mg/mL
- Dosage Form
- INJECTION, POWDER, FOR SUSPENSION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761365
- Drug Class
- Claudin 18.2-directed Cytolytic Antibody [EPC]
- Marketing Start
- 04/24/2025
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is VYLOY used for?
VYLOY contains ZOLBETUXIMAB. It is a injection, powder, for suspension taken intravenous. Consult your doctor for specific uses.
Is VYLOY a controlled substance?
VYLOY is not classified as a controlled substance by the DEA.
What is the generic name for VYLOY?
The generic name for VYLOY is ZOLBETUXIMAB. There are no other listed brand versions of ZOLBETUXIMAB.
What is the NDC code for VYLOY 20 mg/mL?
The NDC (National Drug Code) for VYLOY 20 mg/mL is 0469-4425, listed by Astellas Pharma US, Inc..
Other VYLOY Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)